On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Mark Francis, Managing Director and Global Head of the Healthcare Group at Houlihan Lokey. They discuss the state of healthcare private equity in 2024. Mark shares insights on deal activity, key market impacts, emerging opportunities, and the influence of digital healthcare. He also highlights the big challenges and trends shaping the industry. Finally, we wrap up with Mark’s thoughts on what to expect for the rest of the year.

In this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by his colleague, Sharon Lamb, Partner and head of the U.K. Healthcare Practice Group at McDermott Will & Emery. Together, they debrief the HPE Europe 2024 conference in London, covering key trends, including selective deal activity, biotech and pharma services growth, and the rise of medtech driven by AI. Sharon also highlights the challenges of navigating exits and the regulatory landscape in medtech, as well as the outlook for bioscience deals over the next two years.

On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by David Schuppan, Senior Partner and Co-Head of Healthcare at The Vistria Group, for the very first episode of our Fund Founders series. They set off on an insightful discussion on healthcare trends, investments, and innovation. David shares his perspective on the themes that have driven his career, the businesses he's proud of, and subsectors that have transformed the industry. Tune in as we explore where healthcare is headed, highlighting areas primed for future disruption and meaningful change.